Pfizer Share Holder Equity 1986-2025 | PFE
Pfizer share holder equity from 1986 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
- Pfizer share holder equity for the quarter ending June 30, 2025 was $89.012B, a 1.18% increase year-over-year.
- Pfizer share holder equity for 2024 was $88.497B, a 0.89% decline from 2023.
- Pfizer share holder equity for 2023 was $89.288B, a 6.91% decline from 2022.
- Pfizer share holder equity for 2022 was $95.916B, a 23.82% increase from 2021.
Pfizer Annual Share Holder Equity
(Millions of US $) |
| 2024 |
$88,497 |
| 2023 |
$89,288 |
| 2022 |
$95,916 |
| 2021 |
$77,462 |
| 2020 |
$63,473 |
| 2019 |
$63,447 |
| 2018 |
$63,758 |
| 2017 |
$71,656 |
| 2016 |
$59,840 |
| 2015 |
$64,998 |
| 2014 |
$71,622 |
| 2013 |
$76,620 |
| 2012 |
$81,678 |
| 2011 |
$82,621 |
| 2010 |
$88,265 |
| 2009 |
$90,446 |
| 2008 |
$57,740 |
| 2007 |
$65,010 |
| 2006 |
$71,358 |
| 2005 |
$65,764 |
| 2004 |
$68,278 |
| 2003 |
$65,377 |
| 2002 |
$19,950 |
| 2001 |
$18,293 |
| 2000 |
$16,076 |
| 1999 |
$8,887 |
| 1998 |
$8,810 |
| 1997 |
$7,933 |
| 1996 |
$6,954 |
| 1995 |
$5,507 |
| 1994 |
$4,324 |
| 1993 |
$3,866 |
| 1992 |
$4,719 |
| 1991 |
$5,026 |
| 1990 |
$5,092 |
| 1989 |
$4,536 |
| 1988 |
$4,301 |
| 1987 |
$3,882 |
| 1986 |
$3,415 |
| 1985 |
$2,927 |
Pfizer Quarterly Share Holder Equity
(Millions of US $) |
| 2025-06-30 |
$89,012 |
| 2025-03-31 |
$90,637 |
| 2024-12-31 |
$88,497 |
| 2024-09-30 |
$92,558 |
| 2024-06-30 |
$87,975 |
| 2024-03-31 |
$92,558 |
| 2023-12-31 |
$89,288 |
| 2023-09-30 |
$97,204 |
| 2023-06-30 |
$99,293 |
| 2023-03-31 |
$101,236 |
| 2022-12-31 |
$95,916 |
| 2022-09-30 |
$92,891 |
| 2022-06-30 |
$87,469 |
| 2022-03-31 |
$82,685 |
| 2021-12-31 |
$77,462 |
| 2021-09-30 |
$75,967 |
| 2021-06-30 |
$70,315 |
| 2021-03-31 |
$68,865 |
| 2020-12-31 |
$63,473 |
| 2020-09-30 |
$65,495 |
| 2020-06-30 |
$64,564 |
| 2020-03-31 |
$65,338 |
| 2019-12-31 |
$63,447 |
| 2019-09-30 |
$65,396 |
| 2019-06-30 |
$59,924 |
| 2019-03-31 |
$59,158 |
| 2018-12-31 |
$63,758 |
| 2018-09-30 |
$71,664 |
| 2018-06-30 |
$70,124 |
| 2018-03-31 |
$70,541 |
| 2017-12-31 |
$71,656 |
| 2017-09-30 |
$61,110 |
| 2017-06-30 |
$58,694 |
| 2017-03-31 |
$58,746 |
| 2016-12-31 |
$59,840 |
| 2016-09-30 |
$63,601 |
| 2016-06-30 |
$63,066 |
| 2016-03-31 |
$63,347 |
| 2015-12-31 |
$64,998 |
| 2015-09-30 |
$67,124 |
| 2015-06-30 |
$67,180 |
| 2015-03-31 |
$67,587 |
| 2014-12-31 |
$71,622 |
| 2014-09-30 |
$78,305 |
| 2014-06-30 |
$76,956 |
| 2014-03-31 |
$78,068 |
| 2013-12-31 |
$76,620 |
| 2013-09-30 |
$78,354 |
| 2013-06-30 |
$78,977 |
| 2013-03-31 |
$82,827 |
| 2012-12-31 |
$81,678 |
| 2012-09-30 |
$82,115 |
| 2012-06-30 |
$79,961 |
| 2012-03-31 |
$83,677 |
| 2011-12-31 |
$82,621 |
| 2011-09-30 |
$90,530 |
| 2011-06-30 |
$88,963 |
| 2011-03-31 |
$90,533 |
| 2010-12-31 |
$88,265 |
| 2010-09-30 |
$88,068 |
| 2010-06-30 |
$86,878 |
| 2010-03-31 |
$90,082 |
| 2009-12-31 |
$90,446 |
| 2009-09-30 |
$66,250 |
| 2009-06-30 |
$63,235 |
| 2009-03-31 |
$60,441 |
| 2008-12-31 |
$57,740 |
| 2008-09-30 |
$67,335 |
| 2008-06-30 |
$66,569 |
| 2008-03-31 |
$67,417 |
| 2007-12-31 |
$65,010 |
| 2007-09-30 |
$66,610 |
| 2007-06-30 |
$68,094 |
| 2007-03-31 |
$72,488 |
| 2006-12-31 |
$71,358 |
| 2006-09-30 |
$69,712 |
| 2006-06-30 |
$68,489 |
| 2006-03-31 |
$69,609 |
| 2005-12-31 |
$65,764 |
| 2005-09-30 |
$66,807 |
| 2005-06-30 |
$65,328 |
| 2005-03-31 |
$67,532 |
| 2004-12-31 |
$68,278 |
| 2004-09-30 |
$68,383 |
| 2004-06-30 |
$66,705 |
| 2004-03-31 |
$69,048 |
| 2003-12-31 |
$65,377 |
| 2003-09-30 |
$68,531 |
| 2003-06-30 |
$70,282 |
| 2003-03-31 |
$24,843 |
| 2002-12-31 |
$19,950 |
| 2002-09-30 |
$18,953 |
| 2002-06-30 |
$18,830 |
| 2002-03-31 |
$19,674 |
| 2001-12-31 |
$18,293 |
| 2001-09-30 |
$18,896 |
| 2001-06-30 |
$17,816 |
| 2001-03-31 |
$17,748 |
| 2000-12-31 |
$16,076 |
| 2000-09-30 |
$16,172 |
| 2000-06-30 |
$14,973 |
| 2000-03-31 |
$10,188 |
| 1999-12-31 |
$8,887 |
| 1999-09-30 |
$8,786 |
| 1999-06-30 |
$8,651 |
| 1999-03-31 |
$9,045 |
| 1998-12-31 |
$8,810 |
| 1998-09-30 |
$8,645 |
| 1998-06-30 |
$8,305 |
| 1998-03-31 |
$8,189 |
| 1997-12-31 |
$7,933 |
| 1997-09-30 |
$7,405 |
| 1997-06-30 |
$7,174 |
| 1997-03-31 |
$7,152 |
| 1996-12-31 |
$6,954 |
| 1996-09-30 |
$6,566 |
| 1996-06-30 |
$5,984 |
| 1996-03-31 |
$5,888 |
| 1995-12-31 |
$5,507 |
| 1995-09-30 |
$5,281 |
| 1995-06-30 |
$4,829 |
| 1995-03-31 |
$4,697 |
| 1994-12-31 |
$4,324 |
| 1994-09-30 |
$4,154 |
| 1994-06-30 |
$3,748 |
| 1994-03-31 |
$3,840 |
| 1993-12-31 |
$3,866 |
| 1993-09-30 |
$3,822 |
| 1993-06-30 |
$4,208 |
| 1993-03-31 |
$4,452 |
| 1992-12-31 |
$4,719 |
| 1992-09-30 |
$5,470 |
| 1992-06-30 |
$5,034 |
| 1992-03-31 |
$5,063 |
| 1991-12-31 |
$5,026 |
| 1991-09-30 |
$5,070 |
| 1991-06-30 |
$4,828 |
| 1991-03-31 |
$5,178 |
| 1990-12-31 |
$5,092 |
| 1990-09-30 |
$5,014 |
| 1990-06-30 |
$4,680 |
| 1990-03-31 |
$4,740 |
| 1989-12-31 |
$4,536 |
| 1989-09-30 |
$4,527 |
| 1989-06-30 |
$4,311 |
| 1989-03-31 |
$4,483 |
| 1988-12-31 |
$4,301 |
| 1988-09-30 |
$4,248 |
| 1988-06-30 |
$4,125 |
| 1988-03-31 |
$4,035 |
| 1987-12-31 |
$3,882 |
| 1987-09-30 |
$3,778 |
| 1987-06-30 |
$3,640 |
| 1987-03-31 |
$3,576 |
| 1986-12-31 |
$3,415 |
| 1985-12-31 |
$2,927 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$201.199B |
$100.330B |
|
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
|
